Elusys Therapeutics
Lobbying
$95,000 Spent
Information
Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
covers through Q2, 2012
Lobbying On Behalf of Elusys Therapeutics
-
Names of Lobbyists
-
Firm Hired Amount Edwards Wildman Palmer $50,000 McDermott, Will & Emery $45,000 -
Most Frequently Disclosed Lobbying Issues
- Medical Research & Clin Labs,
- Health Issues
-
Most Frequently Disclosed Bills
Bill No. Title H.R.2405 Pandemic and All-Hazards Preparedness Reauthorization Act of 2011 S.1855 Pandemic and All-Hazards Preparedness Act Reauthorization of 2011
